Abstract
It is widely accepted that after the age of 70 comorbidities become more frequent and organ function decreases. Supportive care in the elderly patient is based on the same principles as for younger patients, but elderly patients are at an increased risk of toxicity from any drug due to age-related decrease in organ function, use of polypharmacy with increased risk of drug–drug interactions, and due to comorbidity. The comprehensive geriatric assessment is a multidisciplinary evaluation of the older patient encompassing a number of essential clinical domains, which provides an important method to evaluate a patient who is to undergo a major medical procedure. The specificities of depression in elderly cancer patients remain a largely unexplored field of research. Not all tools for the assessment of pain are equally reliable in the elderly. Analgesics should be used with care in the elderly who are more susceptible to drug side effects. Guidelines on the use of granulocyte colony-stimulating factors recognize older individuals above the age of 65 as a group at high risk. Malnutrition is observed frequently and leads to low albumin levels, a determinant of toxicity for drug therapy. Compliance needs to be carefully evaluated, particularly in patients with high risk of noncompliance such as elderly with dementia and impaired vision. Osteopenia and osteoporosis are frequent in the elderly, both in females and males. Besides exercise and use of calcium and vitamin D, bisphosphonates or denosumab are recommended for some patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pallis AG, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010; 46:1502–1513.
Dixon DO, Neilan B, Jones S, et al. Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol. 1986; 4:295–305.
Extermann M, Aapro M, Bernabei R, et al. Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005; 55:241–252.
Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002; 20:494–502.
PACE participants, Audisio RA, Pope D, Ramesh HS, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008; 65:156–163.
Spoletini I, Gianni W, Repetto L, et al. Depression and cancer: an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol Hematol. 2008; 65:143–155.
Fisch M. Treatment of depression in cancer. J Natl Cancer Inst Monogr. 2004; 32:105–111.
Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006; 94:372–390.
Henry NL, Stearns V, Flockhart DA, et al. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry. 2008; 165:1251–1255.
Herr K, Garand L. Assessment and measurement of pain in older patients. Clin Geriatr Med. 2001; 17:457–478.
Urban D, Cherny N, Catane R. The management of cancer pain in the elderly. Crit Rev Oncol Hematol. 2010; 73:176–183.
Aapro MS, Cameron DA, Pettengell R, et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the Âincidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumors. Eur J Cancer. 2006; 42:2433–2453.
Repetto L, Biganzoli L, Koehne CH, et al. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating Âfactors in elderly patients with cancer. Eur J Cancer. 2003; 39:2264–2272.
Aapro M, Crawford J, Kamioner D. Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now? Support Care Cancer. 2010; 18:529–541. doi: 10.1007/s00520-010-0816-y.
Blanc-Bisson C, Fonck M, Rainfray M, Soubeyran P, Bourdel-Marchasson I. Undernutrition in elderly patients with cancer: target for diagnosis and intervention. Crit Rev Oncol Hematol. 2008; 67:243–254.
Vellas B, Lauque S, Andrieu S, et al. Nutritional assessment of the elderly. Curr Opin Clin Nutr Metabolic Care. 2001; 4(1):5–8.
John V, Mashru S, Lichtman S. Pharmacological factors influencing anticancer drug selection in the elderly. Drugs Aging. 2003; 20(10):737–759.
Pond GR, Siu LL, Moore M, et al. Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents. J Clin Oncol. 2008; 26:1324–1330.
Jakobsen JN, Herrstedt J. Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients. Crit Rev Oncol Hematol. 2009; 71:214–221.
Hadji P, Body JJ, Aapro MS, et al. Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol. 2008; 19:1407–1416.
Aapro M, Abrahamsson PA, Body JJ, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol. 2008; 19:420–432.
Body JJ, Coleman R, Clezardin P, et al. International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients. Eur J Cancer. 2007; 43:852–858.
Cummings SR, San Martin J, McClung MR, et al. FREEDOM Trial. Denosumab for prevention of fractures in postmenoÂpausal women with osteoporosis. N Engl J Med. 2009; 361:756–765.
Smith MR, Egerdie B, Hernández Toriz N, et al. Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009; 361:745–755.
Santini D, Fratto ME, Galluzzo S, et al. Are bisphosphonates the suitable anticancer drugs for the elderly? Crit Rev Oncol Hematol. 2009; 69:83–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Society for Imaging Informatics in Medicine
About this chapter
Cite this chapter
Aapro, M.S. (2010). Supportive Care in Elderly Cancer Patients. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1225-1_5
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1224-4
Online ISBN: 978-1-4419-1225-1
eBook Packages: MedicineMedicine (R0)